NEW YORK – Everest Medicines said on Sunday that the US Food and Drug Administration cleared an investigational new drug application (IND) seeking permission to begin studying its mRNA vaccine EVM14 ...
The firm's Heart-2 study of VERVE-102, which is designed to inactivate the PCSK9 gene, is already underway in Canada and the UK.
NEW YORK – Angle on Friday said it is seeking to engage with BlissBio Biopharmaceutical to develop the antibody-drug conjugate BB-1701 alongside its circulating tumor cell (CTC) assay, following Eisai ...
Alnylam's RNAi TTR Silencing Drug Amvuttra FDA Approved for Transthyretin Amyloidosis Cardiomyopathy
The drug was already sold for TTR amyloidosis with polyneuropathy, and now is available to patients with hereditary or wild-type ATTR-CM.
NEW YORK – The US Food and Drug Administration on Friday approved Telix's PSMA-PET prostate cancer imaging agent Gozellix (gallium-68 gozetotide injection) to identify PSMA-positive prostate cancer ...
Precision Medicine Online's 2024 survey shows biomarker test expansion but low clinical trial enrollment and long wait times ...
By correcting for ancestral bias in publicly available datasets, PhyloFrame produces better outcomes predictions for ...
Findings from the nationwide survey suggest interest in PGx while highlighting areas for UK policymakers to pay attention to, ...
The firm's stock price dropped 27 percent on Tuesday following the news that the young man died from acute liver failure after getting Elevidys.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback